Eventide Gilead Class N (ETGLX)
| Fund Assets | 2.96B |
| Expense Ratio | 1.36% |
| Min. Investment | $1,000 |
| Turnover | 60.00% |
| Dividend (ttm) | 6.87 |
| Dividend Yield | 12.35% |
| Dividend Growth | 966.98% |
| Payout Frequency | n/a |
| Ex-Dividend Date | Dec 16, 2025 |
| Previous Close | 55.09 |
| YTD Return | 1.87% |
| 1-Year Return | 15.66% |
| 5-Year Return | 1.07% |
| 52-Week Low | 36.01 |
| 52-Week High | 57.06 |
| Beta (5Y) | n/a |
| Holdings | 70 |
| Inception Date | Jul 8, 2008 |
About ETGLX
Eventide Gilead Fund Class N is an actively managed mutual fund that centers on long-term capital appreciation through investment in a diversified portfolio of equity securities. Classified as a mid-cap growth fund, it primarily targets companies with market capitalizations that fall within the middle range of the U.S. equity market, often focusing on businesses demonstrating strong potential for above-average earnings growth. The fund employs a flexible approach, allowing investments across all market capitalizations and geographic regions, including companies outside the United States through direct holdings or American Depository Receipts. Eventide Gilead Fund Class N has a historical emphasis on sectors such as healthcare, technology, and industrials, with notable positions in industry leaders within these categories. The fund is positioned as a vehicle for capturing growth opportunities while integrating a philosophy aimed at creating value for stakeholders and contributing to the common good. Managed by Eventide since its inception in 2008, the fund is recognized for its diversified holdings and active strategy within the mid-cap growth segment.
Performance
ETGLX had a total return of 15.66% in the past year, including dividends. Since the fund's inception, the average annual return has been 16.68%.
Equivalent Funds
These are funds that follow the same index from the other major fund companies.
Top 10 Holdings
32.98% of assets| Name | Symbol | Weight |
|---|---|---|
| Xometry, Inc. | XMTR | 5.63% |
| Guardant Health, Inc. | GH | 4.93% |
| Mirum Pharmaceuticals, Inc. | MIRM | 3.60% |
| Toast, Inc. | TOST | 2.95% |
| US BANK MMDA - USBGFS 9 | n/a | 2.83% |
| Trane Technologies plc | TT | 2.75% |
| iRhythm Holdings, Inc. | IRTC | 2.74% |
| United Rentals, Inc. | URI | 2.59% |
| GE Vernova Inc. | GEV | 2.52% |
| Verona Pharma PLC | VRNA | 2.43% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 16, 2025 | $6.8724 | Dec 17, 2025 |
| Dec 13, 2024 | $0.6441 | Dec 16, 2024 |
| Dec 15, 2022 | $2.2812 | Dec 16, 2022 |
| Dec 16, 2021 | $4.2652 | Dec 17, 2021 |
| Dec 17, 2020 | $0.5114 | Dec 17, 2020 |
| Dec 17, 2019 | $1.3176 | Dec 17, 2019 |